Pharmacokinetics and Toxicokinetic Considerations 2022
DOI: 10.1016/b978-0-323-98367-9.00026-3
|View full text |Cite
|
Sign up to set email alerts
|

Toxicokinetic and toxicodynamic considerations in drug research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 89 publications
0
2
0
Order By: Relevance
“…When these NPs are instilled intranasally, there is a significant increase in the levels of malonaldehyde (MDA), superoxide dismutase, and H 2 O 2 following a timedependent decrease in the glutathione (GSH) levels. 68 5.1.3. Inflammatory Reactions.…”
Section: Toxicological Effects Caused Due Tomentioning
confidence: 99%
See 1 more Smart Citation
“…When these NPs are instilled intranasally, there is a significant increase in the levels of malonaldehyde (MDA), superoxide dismutase, and H 2 O 2 following a timedependent decrease in the glutathione (GSH) levels. 68 5.1.3. Inflammatory Reactions.…”
Section: Toxicological Effects Caused Due Tomentioning
confidence: 99%
“…A few examples of NPs which cause toxicity by this mechanism are Cu NPs, Fe 3 O 4 NPs, and ZnO NPs. When these NPs are instilled intranasally, there is a significant increase in the levels of malonaldehyde (MDA), superoxide dismutase, and H 2 O 2 following a time-dependent decrease in the glutathione (GSH) levels …”
Section: Toxicological Effects Caused Due To Novel Nasal Formulationsmentioning
confidence: 99%